Abstract
Accurate interpretation of the results of GH stimulation tests is of pivotal importance not only in the evaluation of the etiology of growth retardation in children but also in the selection of the best candidates for GH therapy. We performed this study to test a novel immunofunctional GH ( IFGH) assay that makes use of the concept that one GH molecule dimerizes two GH receptors and compared the results with those obtained using two GH assays, the Diagnostic Systems Laboratories ELISA and a Hybritech immunoradiometric assay in 19 children with short stature undergoing routine GH stimulation testing. We also tested 13 normally statured control children to revisit the issue of what constitutes normal GH responses to stimuli, using all three assays and arginine and either L-dopa or insulin-induced hypoglycemia as secretagogues. Concentrations of IGF-I, IGF binding protein-3, and acid labile subunit were measured as well. There was a significant correlation between peak IFGH and Diagnostic Systems Laboratories ELISA GH responses to stimuli (r2 = 0.93) as well as between the Diagnostic Systems Laboratories ELISA and Hybritech immunoradiometric assay (r2 = 0.91). There were no significant differences between the short stature and normal group in peak or mean GH concentrations regardless of the assay used; however, the IGF-I, IGF binding protein-3, and acid labile subunit concentrations were substantially lower in the short stature group. There was a wide spectrum of GH concentrations in the normal group; ∼50% of the children had peak GH concentrations <7 ng/mL, ∼30% <5 ng/mL, and two pubertal normal subjects peaked to only 2 ng/mL with use of both the ELISA and IFGH assays. We conclude that 1) sensitive GH assays, ELISA and immunoradiometric assay, accurately detect a GH capable of generating a biologic signal comparable to an IFGH and 2) that normal GH stimulation test results can be substantially lower than previously accepted. GH-dependent growth factors may be more sensitive indicators of GH sufficiency than GH concentrations in response to pharmacologic stimuli.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- IFGH:
-
immunofunctional GH
- SS:
-
short stature
- IRMA:
-
immunoradiometric assay
- IGFBP-3:
-
IGF binding protein-3
- ALS:
-
acid labile subunit
- DSL:
-
Diagnostic Systems Laboratories
References
Wyatt DT, Mark D, Slyper A 1995 Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 80: 3292–3297.
Celniker AC, Chen AB, Wert RM Jr Sherman BM 1989 Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 68: 469–476.
Root AW, Rosenfield RL, Bongiovanni AM, Eberlein WR 1967 The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics 39: 844–852.
Root AW, Saenz-Rodriguez C, Bongiovanni AM, Eberlein WR 1969 The effect of arginine infusion on plasma growth hormone and insulin in children. J Pediatr 74: 187–197.
Youlton R, Kaplan SL, Grumbach MM 1969 Growth and growth hormone. IV. Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children. Pediatrics 43: 989–1004.
Collu R, Leboeuf G, Letarte J, Ducharme JR 1975 Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents. Pediatrics 56: 262–266.
Weldon VV, Gupta SK, Klingensmith G, Clarke WL, Duck SC, Haymond MW, Pagliara AS 1975 Evaluation of growth hormone release in children using arginine and L- dopa in combination. J Pediatr 87: 540–544.
Lanes R, Hurtado E 1982 Oral clonidine—an effective growth hormone-releasing agent in prepubertal subjects. J Pediatr 100: 710–714.
Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F 1996 Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81: 3323–3327.
Fass B, Lippe BM, Kaplan SA 1979 Relative usefulness of three growth hormone stimulation screening tests. Am J Dis Child 133: 931–933.
Frasier SD 1974 A preview of growth hormone stimulation tests in children. Pediatrics 53: 929–937.
Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK, Addison MG, Gill MS, Whatmore AJ, Clayton PE 1997 Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 82: 531–535.
Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19: 717–797.
Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB Jr 1988 The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 319: 201–207.
Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK 1994 Diagnosis of growth-hormone deficiency in adults. Lancet 343: 1064
Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorn M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83: 382–395.
Strasburger CJ, Wu Z, Pflaum CD, Dressendorfer RA 1996 Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 81: 2613–2620.
Takahashi Y, Shirono H, Arisaka O, Takahashi K, Yagi T, Koga J, Kaji H, Okimur Y, Abe H, Tanaka T, Chihara K 1997 Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest 100: 1159–1165.
Takahashi Y, Chihara K 1998 Clinical significance and molecular mechanisms of bioinactive growth hormone. Int J Mol Med 2: 287–291.
Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S 1995 Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80: 1532–1540.
Cuttler L, Silver JB, Singh J, Marrero U, Finkelstein B, Tannin G 1996 Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA 276: 531–537.
Hintz RL, Attie KM, Baptista J, Roche A 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 340: 502–507.
Vance ML, Mauras N 1999 Growth hormone therapy in adults and children. N Eng J Med 341: 1216
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mauras, N., Walton, P., Nicar, M. et al. Growth Hormone Stimulation Testing in Both Short and Normal Statured Children: Use of an Immunofunctional Assay. Pediatr Res 48, 614–618 (2000). https://doi.org/10.1203/00006450-200011000-00010
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-200011000-00010
This article is cited by
-
Pegvisomant-primed growth hormone (GH) stimulation test is useful in identifying true GH deficient children
Hormones (2017)
-
The role of insulin like growth factor (IGF) — 1 and IGF — binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children
The Indian Journal of Pediatrics (2009)
-
Growth hormone deficiency in children
Pituitary (2008)
-
Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: A proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED)
Journal of Endocrinological Investigation (2006)
